US Bancorp DE Acquires 2,268 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
US Bancorp DE raised its stake in Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 22.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,430 shares of the biopharmaceutical company’s stock after buying an additional 2,268 shares during the quarter. US […]
US Bancorp DE raised its stake in Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 22.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,430 shares of the biopharmaceutical company’s stock after buying an additional 2,268 shares during the quarter. US […]
